首页 > 市场调查报告书 > 製药

感染疾病

市场调查报告书

商品编码

1671837

抗菌药物市场按药物类别、活性频谱、给药途径、应用、分销管道和地区划分

Antibacterial Drugs Market, By Drug Class, By Spectrum of Activity, By Route of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2025年02月06日 | 出版商:

Coherent Market Insights | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球抗生素市场规模估计为 469.1 亿美元，预计到 2032 年将达到 647.4 亿美元，2025 年至 2032 年的复合年增长率为 4.7%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	469.1亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	4.70％	2032 年价值预测	647.4亿美元

图。

抗生素，也称为抗生素，是对抗细菌感染的药物，透过杀死细菌或抑制细菌生长来发挥作用。它被广泛用于治疗多种感染疾病，包括肺炎、结核病、炭疽、梅毒、麻风病和李斯特菌病。预计感染疾病流行、製药公司对抗生素研究的投资增加以及强大的开发新药管道等因素将在预测期内推动市场成长。然而，政府对新抗生素核准和抗生素抗药性发展的严格监管可能会在一定程度上抑制市场的成长。

市场动态：

在预计预测期内，细菌感染疾病盛行率增加、新产品推出和强大的药物管道等关键因素将推动全球抗生素市场的发展。根据美国疾病管制与预防中心（CDC）统计，光是2020年，美国就有超过280万例抗生素抗药性感染，导致超过35,000人死亡。这对有效抗菌药物产生了巨大的需求。此外，领先的公司也不断注重研发，开发创新药物。例如，2022年8月，辉瑞公司获得美国FDA核准一种新的抗生素治疗药物Relibactam，用于治疗复杂的尿道感染和腹腔内感染疾病。然而，有关新抗生素核准的严格规定以及抗生素抗药性的日益发展等因素预计会抑制市场的成长。此外，专注于开发噬菌体疗法等替代治疗方法预计将在未来几年提供有利可图的机会。

本研究的主要特点

本报告对全球抗生素市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2025 年为基准年。

它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球抗菌药物市场的主要企业。

研究涉及的主要企业包括辉瑞、雅培、默克、葛兰素史克、礼来公司、百时美施贵宝公司、强生、赛诺菲、拜耳和诺华。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球抗菌药物市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员将透过用于分析全球抗菌药物市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 46.91 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.70%	2032 Value Projection:	USD 64.74 Bn

Antibacterial drugs, also known as antibiotics, are medicines that fight bacterial infections and work by either killing or inhibiting the growth of bacteria. They are widely used for the treatment of various infections such as pneumonia, tuberculosis, anthrax, syphilis, leprosy, and listeriosis. Factors such as growth in the prevalence of infectious diseases, increasing investment by pharmaceutical companies in antibiotic research, and strong pipeline of newly developed drugs are expected to drive the market growth during the forecast period. However, stringent government regulations for the approval of new antibiotics and antibiotic resistance development may restrain the market growth to a certain extent.

Market Dynamics:

Key factors, such as increasing prevalence of bacterial infections, new product launches, and strong pipeline drugs, are projected to drive the global antibacterial drugs market during the forecast period. As per Centers for Disease Control and Prevention (CDC), in 2020 alone over 2.8 million antibiotic-resistant infections occurred in the U.S. and more than 35,000 people died. This creates significant demand for effective antibacterial drugs. Furthermore, large players are continuously focusing on R&D to develop innovative drugs. For instance, in August 2022, Pfizer Inc. received USFDA approval for its new antibiotic treatment, relebactam, to treat complicated urinary tract and intra-abdominal infections. However, factors like stringent regulations for approval of new antibiotics and increasing antibiotic resistance development are anticipated to restrain the market growth. Moreover, focus on the development of alternative treatment methods like bacteriophage therapy is expected to present lucrative opportunities in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global antibacterial drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2025 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global antibacterial drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Abbott, Merck, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb Company, Johnson & Johnson, Sanofi, Bayer, and Novartis

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibacterial drugs market

Market Segmentation

By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Penicillins
- Cephalosporins
- Aminoglycosides
- Tetracyclines
- Macrolides
- Fluoroquinolones
- Sulfonamides
- Others
By Spectrum of Activity Insights (Revenue, USD Bn, 2020 - 2032)
- Broad-spectrum Antibiotics
- Narrow-spectrum Antibiotics
By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Topical
- Intravenous
- Other Routes
By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Skin Infections
- Respiratory Infections
- Urinary Tract Infections
- Septicemia
- Ear Infections
- Gastrointestinal Infections
- Other Applications
By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Novartis International AG
- GlaxoSmithKline plc
- Sanofi
- Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Astellas Pharma Inc.
- Johnson & Johnson
- Amgen Inc.
- Bayer AG
- Eli Lilly and Company
- AstraZeneca plc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Antibacterial Drugs Market, By Drug Class
- Global Antibacterial Drugs Market, By Spectrum of Activity
- Global Antibacterial Drugs Market, By Route of Administration
- Global Antibacterial Drugs Market, By Application
- Global Antibacterial Drugs Market, By Distribution Channel
- Global Antibacterial Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Antibacterial Drugs Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Penicillins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cephalosporins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fluoroquinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sulfonamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Antibacterial Drugs Market, By Spectrum of Activity, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Broad-spectrum Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Narrow-spectrum Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Antibacterial Drugs Market, By Route of Administration 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Routes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Antibacterial Drugs Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Skin Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Septicemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ear Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gastrointestinal Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Antibacterial Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Antibacterial Drugs Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
Africa

10. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Abbott Laboratories
Novartis International AG
GlaxoSmithKline plc
Sanofi
Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Astellas Pharma Inc.
Johnson & Johnson
Amgen Inc.
Bayer AG
Eli Lilly and Company
AstraZeneca plc

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

抗菌药物市场按药物类别、活性频谱、给药途径、应用、分销管道和地区划分